Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F17%3A10367303" target="_blank" >RIV/00179906:_____/17:10367303 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.radonc.2017.02.017" target="_blank" >http://dx.doi.org/10.1016/j.radonc.2017.02.017</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.radonc.2017.02.017" target="_blank" >10.1016/j.radonc.2017.02.017</a>
Alternative languages
Result language
angličtina
Original language name
Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer
Original language description
Background: To test the hypothesis that atlas-based active bone marrow (ABM) -sparing intensity modulated radiation therapy (IMRT) yields similar dosimetric results compared to custom ABM-sparing IMRT for cervical cancer patients. Methods: We sampled 62 cervical cancer patients with pre-treatment FDG-PET/CT in training (n = 32) or test (n = 30) sets. ABM was defined as the subvolume of the pelvic bone marrow (PBM) with standardized uptake value (SUV) above the mean on the average FDG-PET image (ABM(Atlas)) vs the individual's PET (ABM(custom)). Both were deformed to the planning CI'. Overlap between the two subvolumes was measured using the Dice coefficient. Three IMRT plans designed to spare PBM, ABM(Atlas), or ABM(custom) were compared for 30 test patients. Dosimetric parameters were used to evaluate plan quality. Results: ABM(Atlas) and ABM(custom) volumes were not significantly different (p = 0.90), with a mean Dice coefficient of 0.75, indicating good agreement. Compared to IMRT plans designed to spare PBM and ABM(custom), ABM(Atlas)-Sparing IMRT plans achieved excellent target coverage and normal tissue sparing, without reducing dose to ABMcustom, (mean ABM(custom) dose 29.4 Gy vs. 27.1 Gy vs. 26.9 Gy, respectively; p = 0.10); however, PTV coverage and bowel sparing were slightly reduced. Conclusions: Atlas-based ABM sparing IMRT is clinically feasible and may obviate the need for customized ABM-sparing as a strategy to reduce hematologic toxicity.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Radiotherapy and Oncology
ISSN
0167-8140
e-ISSN
—
Volume of the periodical
123
Issue of the periodical within the volume
2
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
6
Pages from-to
325-330
UT code for WoS article
000403028800025
EID of the result in the Scopus database
2-s2.0-85019613782